Study: Antidepressant Paxil might prevent heart failure

Share this article:

The antidepressant Paxil has shown promise in strengthening the heart, new research suggests.

In a discovery that University of Michigan researcher John Tesmer, Ph.D., described as “completely serendipitous,” the drug paroxetine, a.k.a. Paxil, inhibits G protein-coupled receptor kinase 2. That's a protein that becomes over-expressed when people have heart failure.

According to Tesmer, paroxetine improved the strength of the heart's contractions in an animal model, without interfering with the heart rate. Although the drug is not currently prescribed in doses large enough to have a therapeutic effect, further development of the drug's key compounds could yield leads within the next several years, researchers said.

The only caveat: SSRIs, often used to treat depression in nursing home residents, have been associated with an increased risk of falls in the elderly.

The study was published online in ACS Chemical Biology.

Share this article:

More in News

CMS expands therapy payment research

The government is expanding its research into alternative therapy payments, to consider more holistic changes to the way Medicare reimburses skilled nursing facilities, the Centers for Medicare & Medicaid Services announced Tuesday.

CDC tightens Ebola guidelines for healthcare workers

The Centers for Disease Control and Prevention has issued more stringent guidelines for how healthcare workers should interact with Ebola patients, following an outcry from nurses and other professionals.

Nonprofit providers face alarming market forces, must rally, LeadingAge chairman says

Nonprofit providers face alarming market forces, must rally, ...

Nonprofit long-term care providers must work together to address alarming trends, or their market share could plummet and the sector as a whole could falter, LeadingAge Chairman David Gehm told ...